Published in J Neurovirol on August 18, 2016
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci (2007) 3.73
Challenges in the Elimination of Pediatric HIV-1 Infection. N Engl J Med (2016) 3.44
HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17
Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol (2010) 2.96
Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis (2009) 2.49
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
Advanced statistics: statistical methods for analyzing cluster and cluster-randomized data. Acad Emerg Med (2002) 2.26
Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci (2008) 2.20
Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics (1986) 2.09
Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS (1999) 1.89
Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.72
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol (2013) 1.69
Understanding the timing of HIV transmission from mother to infant. JAMA (2001) 1.60
Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr (2005) 1.59
Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics (2008) 1.55
Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS (2004) 1.53
Cerebral injury in perinatally HIV-infected children compared to matched healthy controls. Neurology (2015) 1.52
Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology (2005) 1.51
Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.47
Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States. Clin Infect Dis (2015) 1.45
Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science (1969) 1.35
Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. Eur J Paediatr Neurol (2006) 1.31
Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J (2007) 1.30
Cognitive impulsivity and HIV serostatus in substance dependent males. J Int Neuropsychol Soc (2004) 1.28
Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy. Arch Pediatr Adolesc Med (2005) 1.25
Gap detection deficits in humans with tinnitus as assessed with the acoustic startle paradigm: does tinnitus fill in the gap? Hear Res (2012) 1.25
Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett (2001) 1.23
Methylphenidate improves HIV-1-associated cognitive slowing. J Neuropsychiatry Clin Neurosci (2001) 1.23
The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol (2009) 1.21
Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy. Pediatrics (2007) 1.21
Cognitive development in school-age children with vertically transmitted HIV infection. Dev Neuropsychol (2002) 1.17
Neurologic complications of HIV disease and their treatment. Top HIV Med (2009) 1.13
Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS (2013) 1.10
Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology (2006) 1.09
Retracted Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflammation (2011) 1.06
Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology (2003) 1.05
Modification of the startle reflex in the rat by changes in the auditory and visual environments. J Comp Physiol Psychol (1971) 1.05
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol (2012) 1.02
Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead. Child Neuropsychol (2014) 1.02
Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response. Int J Dev Neurosci (2006) 1.02
Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures. Brain Res (2008) 1.01
Neonatal intrahippocampal glycoprotein 120 injection: the role of dopaminergic alterations in prepulse inhibition in adult rats. J Pharmacol Exp Ther (2006) 1.00
High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood. J Acquir Immune Defic Syndr (2010) 0.95
Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy. Rev Med Virol (2014) 0.95
Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res (2012) 0.95
Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol (2007) 0.95
Neurodevelopmental outcomes in children with HIV infection under 3 years of age. Dev Med Child Neurol (2006) 0.95
Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. J Neuroimmune Pharmacol (2009) 0.94
Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol (2012) 0.94
Computerized and traditional stroop task dysfunction in HIV-1 infection. Neuropsychology (1999) 0.93
Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol (2012) 0.89
Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat. J Neuroimmune Pharmacol (2013) 0.87
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
The prevalence of motor delay among HIV infected children living in Cape Town, South Africa. Int J Rehabil Res (2009) 0.86
Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat. J Neurovirol (2010) 0.85
Effect of in utero cocaine exposure on startle and its modification. Dev Pharmacol Ther (1989) 0.85
HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens. J Neuroimmune Pharmacol (2014) 0.84
Acoustic startle reduction in cocaine dependence persists for 1 year of abstinence. Psychopharmacology (Berl) (2010) 0.83
CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation. AJNR Am J Neuroradiol (1992) 0.83
Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc (2013) 0.83
HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children. J Mol Neurosci (2005) 0.83
Diminished acoustic startle in chronic cocaine users. Neuropsychopharmacology (2000) 0.82
Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation. Int J Dev Neurosci (2014) 0.81
Modeling deficits in attention, inhibition, and flexibility in HAND. J Neuroimmune Pharmacol (2014) 0.81
Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes. Neurology (1996) 0.80
Ontogeny of starvation-induced behavioral arousal in the rat. J Comp Physiol Psychol (1971) 0.80
HIV-1 proteins, Tat and gp120, target the developing dopamine system. Curr HIV Res (2015) 0.80
Cholinergic modulation of adrenergic arousal in the developing rat. J Comp Physiol Psychol (1970) 0.80
Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIV. Mol Imaging (2014) 0.80
The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants. AIDS Care (2013) 0.79
HIV-Related Cognitive Impairment of Orphans in Myanmar With Vertically Transmitted HIV Taking Antiretroviral Therapy. Pediatr Neurol (2015) 0.78
Growth Patterns of HIV Infected Indian Children in Response to ART: A Clinic Based Cohort Study. Indian J Pediatr (2015) 0.78
Ontogeny of behavioral arousal. A comparative study. J Comp Physiol Psychol (1972) 0.78
Neurocognitive function in HIV-positive children in a developing country. Int J Infect Dis (2013) 0.78
Some statistical and experimental considerations in the use of the analysis-of-variance procedure. Am J Physiol (1984) 0.76
A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat. J Neuroimmune Pharmacol (2016) 0.75